Age-related and disease-specific changes in B-cell profiles in older adults with immune thrombocytopenia. [PDF]
Monzón Manzano E +15 more
europepmc +1 more source
Evaluating the Innovator Training Program: Strengthening Evidence-Based Practice and Building Implementation Capability in the Australian Aged Care Workforce. [PDF]
Champion S, Bilton R, Gordon S.
europepmc +1 more source
Emerging therapeutic advances for immune thrombocytopenia: highlights from selected early‑phase and pivotal trials at the 2025 ASH annual meeting. [PDF]
Cao L, Wang Z, Xiang Q.
europepmc +1 more source
ATRA improves megakaryopoiesis in immune thrombocytopenia through up-regulating the HIF-1α/SPHK2/S1P pathway. [PDF]
Huang QS +18 more
europepmc +1 more source
Development and validation of a predictive model for chronic or persistent immune thrombocytopenia in children incorporating anti-glycoprotein IIb antibody: a retrospective cohort study utilizing LASSO regression and bootstrap stability analysis. [PDF]
Yang X +6 more
europepmc +1 more source
Single-Cell Analysis Highlights Pivotal Role of Eosinophil-Basophil Mast Cell Progenitor-Related Mechanism in Primary Immune Thrombocytopenia. [PDF]
Xie M +6 more
europepmc +1 more source
Real-world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL-AVA 3.5 study. [PDF]
Piatek C +8 more
europepmc +1 more source
Platelet-related parameters at initial diagnosis for predicting the risk of chronicity in children with newly diagnosed immune thrombocytopenia. [PDF]
Zheng S, Liang J, Jiang W, Han R, Guo X.
europepmc +1 more source
Multisystem hemorrhage in a very preterm infant born to a mother with immune thrombocytopenia: a case report and literature review. [PDF]
Liu K, Li M, Shi W, Wu Y, Yang Q.
europepmc +1 more source

